Life Sciences & Biomedicine Otorhinolaryngology Science & Technology Surgery
Background. Head and neck squamous cell carcinoma (HNSCC) is potentially curable, but treatment planning remains a challenge. Oncogenic human papillomavirus (HPV)-positive disease is often associated with a good prognosis compared with HPV-negative disease. However, some HPV-positive HNSCC recurs, often with distant metastases and significant treatment resistance.
Methods and Results. We performed p16 immunohistochemistry (IHC), in situ hybridization (ISH) for high-risk HPV, and comprehensive genomic profiling on oropharyngeal HNSCC with basaloid features and particularly aggressive disease course, noting a rare genetic event: a deleting mutation (exons 5-17) of the tumor suppressor and dominant cell cycle regulator retinoblastoma 1 (RB1). Genomic and transcriptomic data available through FoundationOne and The Cancer Genome Atlas (TCGA) were reviewed for additional HNSCC cases with RB1 alterations.
Conclusion. RB1 alterations may have important prognostic implications, particularly in the context of high p16 expression, in both HPV-positive and HPV-negative HNSCC. (C) 2016 Wiley Periodicals, Inc.
Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1
Creators
Tim N. Beck - Fox Chase Cancer Center
Chad H. Smith - Fox Chase Cancer Center
Douglas B. Flieder - Fox Chase Cancer Center
Thomas J. Galloway - Fox Chase Cancer Center
John A. Ridge - Fox Chase Cancer Center
Erica A. Golemis - Drexel University
Ranee Mehra - Fox Chase Cancer Center
Publication Details
Head & neck, v 39(3), pp E34-E39
Publisher
Wiley
Number of pages
6
Grant note
U54 CA149147; R21 CA181287; R21 CA191425; P50 CA083638 / National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
P30 CA006927 / National Cancer Institute Core Grant
P50CA083638 / NATIONAL CANCER INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)
F30 CA180607 / Ruth L. Kirschstein National Research Service Award F30 fellowship from the National Institutes of Health
Resource Type
Journal article
Language
English
Academic Unit
Biochemistry and Molecular Biology
Web of Science ID
WOS:000397334700001
Scopus ID
2-s2.0-84997771436
Other Identifier
991019319070804721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: